Cubist Systematic Strategies’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-61,803
| Closed | -$727K | – | 2652 |
|
|
2019
Q2 | $727K | Buy |
61,803
+17,062
| +38% | +$201K | 0.01% | 1227 |
|
|
2019
Q1 | $611K | Buy |
44,741
+28,144
| +170% | +$384K | 0.02% | 1058 |
|
|
2018
Q4 | $170K | Buy |
+16,597
| New | +$170K | 0.01% | 1602 |
|
|
2018
Q3 | – | Sell |
-21,639
| Closed | -$342K | – | 2177 |
|
|
2018
Q2 | $342K | Sell |
21,639
-5,975
| -22% | -$94.4K | 0.02% | 1000 |
|
|
2018
Q1 | $351K | Buy |
27,614
+3,405
| +14% | +$43.3K | 0.02% | 1044 |
|
|
2017
Q4 | $277K | Buy |
24,209
+836
| +4% | +$9.57K | 0.01% | 1307 |
|
|
2017
Q3 | $286K | Buy |
23,373
+20,089
| +612% | +$246K | 0.02% | 1206 |
|
|
2017
Q2 | $38K | Buy |
+3,284
| New | +$38K | ﹤0.01% | 1571 |
|
|
2017
Q1 | – | Sell |
-4,013
| Closed | -$83K | – | 1977 |
|
|
2016
Q4 | $83K | Buy |
4,013
+2,633
| +191% | +$54.5K | 0.01% | 1521 |
|
|
2016
Q3 | $45K | Sell |
1,380
-20
| -1% | -$652 | ﹤0.01% | 1579 |
|
|
2016
Q2 | $35K | Buy |
1,400
+448
| +47% | +$11.2K | ﹤0.01% | 1606 |
|
|
2016
Q1 | $23K | Sell |
952
-1,190
| -56% | -$28.8K | ﹤0.01% | 1522 |
|
|
2015
Q4 | $71K | Sell |
2,142
-4,127
| -66% | -$137K | ﹤0.01% | 1560 |
|
|
2015
Q3 | $205K | Sell |
6,269
-6,226
| -50% | -$204K | 0.01% | 1466 |
|
|
2015
Q2 | $662K | Buy |
12,495
+7,071
| +130% | +$375K | 0.03% | 796 |
|
|
2015
Q1 | $157K | Buy |
5,424
+4,918
| +972% | +$142K | 0.01% | 1596 |
|
|
2014
Q4 | $15K | Buy |
+506
| New | +$15K | ﹤0.01% | 1824 |
|